Takeda Pharmaceuticals Reports - Industry Research
Reports Featuring Takeda Pharmaceuticals
Insomnia Treatment Market
The Insomnia Treatment Market size is estimated at USD 3.58 billion in 2024, and is expected to reach USD 4.60 billion by 2029, growing at a CAGR of 5.16% during the forecast period (2024-2029).
Japan Pharmaceutical Market
The Japan Pharmaceutical Market size is estimated at USD 88 billion in 2024, and is expected to reach USD 91.94 billion by 2029, growing at a CAGR of 0.88% during the forecast period (2024-2029).
Global Orphan Drugs Market
The Global Orphan Drugs Market size is estimated at USD 217.35 billion in 2024, and is expected to reach USD 294.17 billion by 2029, growing at a CAGR of 6.24% during the forecast period (2024-2029).
Proton Pump Inhibitors Market
The proton pump inhibitors market is poised to grow at a CAGR of 4.5% during the forecast period of the study.
North America Biguanide Market
The North America Biguanide Market size is estimated at USD 1.36 billion in 2024, and is expected to reach USD 1.58 billion by 2029, growing at a CAGR of 2.59% during the forecast period (2024-2029).
Inflammatory Bowel Disease (IBD) Therapeutics Market
The Inflammatory Bowel Disease Therapeutics Market size in terms of Equal-5.15 is expected to grow from USD 24.46 billion in 2024 to USD 31.43 billion by 2029, at a CAGR of 5.15% during the forecast period (2024-2029).
Japan Diabetes Drugs Market
The Japan Diabetes Drugs Market size is estimated at USD 3.15 billion in 2024, and is expected to reach USD 4.03 billion by 2029, growing at a CAGR of 4.98% during the forecast period (2024-2029).
North America Alpha-Glucosidase Inhibitors Market
The North America Alpha-Glucosidase Inhibitors Market size is estimated at USD 0.28 billion in 2024, and is expected to reach USD 0.32 billion by 2029, growing at a CAGR of 2.5% during the forecast period (2024-2029).
Smoking Cessation Aids Market
The smoking cessation aid market is expected to register a CAGR of 12.5% over the forecast period.
Gastrointestinal Therapeutics Market
The Gastrointestinal Therapeutics Market size is estimated at USD 0.08 billion in 2024, and is expected to reach USD 0.1 billion by 2029, growing at a CAGR of 3.80% during the forecast period (2024-2029).
Global Polycystic Ovarian Syndrome Treatment Market
The polycystic ovarian syndrome (PCOS) treatment market is expected to register a growth rate of 5.2% over the forecast period., 2022-2027.
Gastroesophageal Reflux Disease Market
The gastroesophageal reflux disease market is poised to grow at a CAGR of 4.3% over the forecast period.
Global Constipation Treatment Market
The constipation treatment market is expected to register a CAGR of nearly 6.9% during the forecast period of 2022-2027.
Red Biotechnology Market
The red biotechnology market is expected to register a CAGR of 6.1% over the forecast period.
Plasma Protein Therapeutics Market
The plasma protein therapeutics market has been projected to register a CAGR of 5.3% over the forecast period.
Global Guillain-Barre Syndrome Market
The Guillain-Barre Syndrome Market studied is anticipated to grow at a CAGR of 5.2% during the forecast period, 2022-2027.
Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Market
The Europe Dipeptide Peptidase 4 Inhibitors Market size is estimated at USD 1.79 billion in 2024, and is expected to reach USD 2.04 billion by 2029, growing at a CAGR of 2.73% during the forecast period (2024-2029).
Global Gout Therapeutics Market
The Gout Therapeutics market is anticipated to grow with a CAGR of 15.5%, over the forecast period (2022 - 2027).
Global Rare Hemophilia Factors Market
The rare hemophilia factors market is expected to record a CAGR of 4.3% over the forecast period (2022-2027).
Global Intravenous Immunoglobulin Market
The intravenous immunoglobulin market is expected to register a CAGR of 7.13% over the forecast period, 2022-2027.
Short Bowel Syndrome Market
The short bowel syndrome (SBS) market is anticipated to grow with a CAGR of 12.1%, during the forecast period.
Chronic Myelogenous Leukemia Treatment Market
The chronic myelogenous leukemia (CML) treatment market is expected to register a CAGR of 5.3% over the forecast period.
Global Narcolepsy Therapeutics Market
The narcolepsy therapeutics market is anticipated to witness a CAGR of 9.9% during the forecast period (2022-2027).
Myelodysplastic Syndrome (MDS) Treatment Market
The myelodysplastic syndrome (MDS) treatment market is projected to register a CAGR of 6.5% during the forecast period, 2022-2027.
Global Myeloproliferative Disorders (MPD) Treatment Market
The myeloproliferative disorders (MPD) treatment market is expected to register a CAGR of 4.9% over the forecast period.
Global Hereditary Angioedema Therapeutics Market
The hereditary angioedema therapeutics market is expected to register a CAGR of 8.5% during the forecast period.
Lysosomal Storage Disease Treatment Market
The lysosomal storage disease treatment market is expected to register a CAGR of 8.2% during the forecast period.
Enzyme Replacement Therapy Market
The enzyme replacement therapy market is expected to register a CAGR of 7.7% during the forecast period.
Sleep Disorders Treatment Market
The sleep disorders treatment market is anticipated to witness a CAGR of nearly 7.1% during the forecast period.
Preterm Birth Prevention and Management Market
The preterm birth prevention and management market is expected to register a CAGR of 5.4% over the forecast period.
Global Addison's Disease Treatment Market
Addison's Disease Treatment market is projected to register a CAGR of 4.1% during the forecast period (2022 - 2027).
Central Nervous System (CNS) Stimulant Drugs Market
The central nervous system (CNS) stimulant drugs market is expected to register a CAGR of 5.5% over the forecast period.
Alpha-glucosidase Inhibitors Market
The Alpha-glucosidase Inhibitors Market size is estimated at USD 4.76 billion in 2024, and is expected to reach USD 5.30 billion by 2029, growing at a CAGR of 2.17% during the forecast period (2024-2029).
Biguanides Market
The Biguanides Market size is estimated at USD 5.20 billion in 2024, and is expected to reach USD 5.76 billion by 2029, growing at a CAGR of 2.07% during the forecast period (2024-2029).
Von Willebrand Disease Treatment Market
The Von Willebrand disease (VWD) treatment market is expected to register a CAGR of 6.5% during the forecast period.
Antithrombin Market
The antithrombin market is expected to register a CAGR of 4.3% over the forecast period.
Global Primary Immunodeficiency Therapeutics Market
The Primary Immunodeficiency Therapeutics Market is expected to register a CAGR of 6.1% during the forecast period.
Subcutaneous Immunoglobulin Market
The subcutaneous immunoglobulin market studied was projected to grow with a CAGR of nearly 13.3% over the forecast period.
Blood Disorder Therapeutics Market
The Blood Disorder Therapeutics Market is expected to register a CAGR of 6.2% during the forecast period.
Multiple Myeloma Market
The multiple myeloma market is expected to witness a CAGR of 6% over the forecast period.
Global Pericarditis Drugs Market
The pericarditis drugs market is expected to register a CAGR of 5.2% over the forecast period (2022-2027).
Japan Container Glass Market
The Japan Container Glass Market is expected to register a CAGR of 3.2% during the forecast period (2020 - 2027).
MEA Uterine Cancer Therapeutics & Diagnostics Market
The Middle East & Africa Uterine Cancer Therapeutics & Diagnostics Market is expected to grow with a CAGR of 5.7% during the forecasted period.
Uterine Cancer Therapeutics & Diagnostics Market
The Uterine Cancer Therapeutics & Diagnostics Market is expected to witness a growth of 6% CAGR owing to the growing awareness of uterine cancer and increasing healthcare expenditure.
APAC Uterine Cancer Therapeutics & Diagnostics Market
The Asia-Pacific Uterine Cancer Therapeutics & Diagnostics Market is expected to register a CAGR of 2.5% during the forecast period.
Plasma Protease C1-inhibitor Market
The Plasma Protease C1-inhibitor Treatment Market is expected to experience a significant growth over the forecast period due to the growing incidence of hereditary angioedema (HAE).
Hunter Syndrome Treatment Market
The hunter syndrome treatment market is expected to be valued at USD 1,265 million, at a CAGR of nearly 5.2%, during the forecast period.
Ubiquitin Proteasome Market
The Ubiquitin Proteasome market studied is anticipated to grow with a CAGR of nearly 3.9%, during the forecast period.
Fabry Disease Treatment Market
The Fabry disease treatment market is expected to register a CAGR of 6.8% over the forecast period.
APAC Biguanide Market
The APAC Biguanide Market size is estimated at USD 1.97 billion in 2024, and is expected to reach USD 2.17 billion by 2029, growing at a CAGR of 2% during the forecast period (2024-2029).
Europe Alpha-Glucosidase Inhibitors Market
The Europe Alpha-Glucosidase Inhibitors Market size is expected to reach USD 1 billion over the forecast year, growing at a CAGR of 2.20% during the forecast period.
Latin America Alpha-Glucosidase Inhibitors Market
The Latin America Alpha-Glucosidase Inhibitors Market size is expected to grow from USD 72.47 million in current year to USD 85.24 million by forecast year, at a CAGR of 3.30% during the forecast period.
Middle East and Africa Alpha-Glucosidase Inhibitors Market
The Middle-East and Africa Alpha-Glucosidase Inhibitors Market size is estimated at USD 57.37 million in current year, and is expected to reach USD 68.46 million by forecast year, growing at a CAGR of 3.60% during the forecast period.
Asia-Pacific Alpha-Glucosidase Inhibitors Market
The Asia-Pacific Alpha-Glucosidase Inhibitors Market size is estimated at USD 4.14 billion in current year, and is expected to reach USD 4.64 billion by forecast year, growing at a CAGR of 2.30% during the forecast period.
Other Reports Covering Takeda Pharmaceuticals
Biotechnology
- Biopharmaceuticals Market
- Drug Discovery Market
- Enzyme Replacement Therapy Market
- Global Autologous Cell Therapy Market
- Global Oncology Clinical Trials Market
- Pharmaceutical Manufacturing Market
- Plasma Fractionation Market
- Plasma Protein Therapeutics Market
- Red Biotechnology Market
- Stem Cell Manufacturing Market
Device Drug Combination
- APAC Ovarian Cancer Diagnostics & Therapeutics Market Size
- APAC Uterine Cancer Therapeutics & Diagnostics Market
- Crohn's Disease Diagnostic and Therapeutic Market
- Gastroesophageal Reflux Disease Market
- Global Non-alcoholic Steatohepatitis Therapeutics and Diagnostics Market
- Hepatitis C Market
- Indonesia Oral Anti-Diabetic Drug Market
- MEA Uterine Cancer Therapeutics & Diagnostics Market
- New Zealand Insulin Drugs and Devices Market
- North America Uterine Cancer Diagnostics & Treatment Market
- Philippines Oral Anti-Diabetic Drug Market
- South Africa Oral Antidiabetic Drug Market
- Thailand Oral Antidiabetic Drug Market
- Type 2 Diabetes Drugs And Devices Market
- Vietnam Insulin Drug And Delivery Device Market
- Vietnam Oral Anti-Diabetic Drug Market
Pharmaceuticals
- Preventive Vaccines Market
- Alpha-glucosidase Inhibitors Market
- Anemia Treatment Market
- Antacids Market
- Anti-obesity Drugs Market
- Antibody-drug Conjugates Market
- Antithrombin Market
- APAC Biguanide Market
- Asia-Pacific Alpha-Glucosidase Inhibitors Market
- Asia-Pacific Diabetes Care Drugs Market
- Asia-Pacific Dipeptide Peptidase 4 (DPP-4) Inhibitors Market
- Asia-Pacific Oral Anti-Diabetic Drug Market
- Asia-Pacific Over-the-counter (OTC) Drugs Market
- Australia Diabetes Care Drugs Market
- Biguanides Market
- Blood Disorder Therapeutics Market
- Bone Cancer Treatment Market
- Brazil Diabetes Drugs Market
- Brazil Oral Anti-Diabetic Drug Market
- Central Nervous System (CNS) Stimulant Drugs Market
- Central Nervous System Therapeutics Market
- China Diabetes Care Drugs Market
- Chronic Myelogenous Leukemia Treatment Market
- Cytomegalovirus Treatment Market
- Denmark Pharmaceutical Market
- Dipeptide Peptidase 4 (DPP-4) Inhibitors Market
- Egypt Diabetes Drugs Market
- Endocrinology Drugs Market
- Epilepsy Drugs Market
- Europe Alpha-Glucosidase Inhibitors Market
- Europe Biguanide Market
- Europe Diabetes Drugs Market
- Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Market
- Europe Oral Anti-Diabetic Drug Market
- Fabry Disease Treatment Market
- France Diabetes Drugs Market
- Gastrointestinal Therapeutics Market
- Germany Diabetes Drugs Market
- Germany OTC Drug Market
- Global Addison's Disease Treatment Market
- Global Attention Deficit Hyperactivity Disorder Market
- Global Cancer Therapy Market
- Global Cholera Vaccines Market
- Global Colorectal Cancer Therapeutics Market
- Global Constipation Treatment Market
- Global Endometrial Cancer Market
- Global Ethical Pharmaceuticals Market
- Global Gout Therapeutics Market
- Global Guillain-Barre Syndrome Market
- Global Hematologic Malignancies Treatment Market
- Global Hereditary Angioedema Therapeutics Market
- Global Herpes Zoster Infection Treatment Market
- Global Hypersomnia Treatment Market
- Global Infectious Disease Drugs Market
- Global Intravenous Immunoglobulin Market
- Global Myeloproliferative Disorders (MPD) Treatment Market
- Global Narcolepsy Therapeutics Market
- Global Opioid Induced Constipation Market
- Global Orphan Drugs Market
- Global Pericarditis Drugs Market
- Global Polycystic Ovarian Syndrome Treatment Market
- Global Primary Immunodeficiency Therapeutics Market
- Global Psoriasis Drugs Market
- Global Rare Hemophilia Factors Market
- Global Varicella Vaccine Market
- Global Waldenstrom's Macroglobulinemia (WM) Treatment Market
- Head and Neck Cancer Therapeutics Market
- Hunter Syndrome Treatment Market
- Immunoglobulin Market
- India Diabetes Care Drugs Market
- India Oral Anti-Diabetic Drug Market
- India Over-the-counter Drugs (OTC) Market
- Indonesia Diabetes Care Drugs Market
- Insomnia Treatment Market
- Iran Diabetes Care Drugs Market
- Italy Diabetes Drugs Market
- Italy Oral Anti-Diabetic Drug Market
- Japan Diabetes Drugs Market
- Japan Oral Anti-Diabetic Drug Market
- Japan Pharmaceutical Market
- Latin America Alpha-Glucosidase Inhibitors Market
- Latin America Biguanide Market
- Latin America Diabetes Care Drugs Market
- Latin America Dipeptide Peptidase 4 (DPP-4) Inhibitors Market
- Latin America Oral Anti-Diabetic Drug Market
- Liver Diseases Therapeutics Market
- Lysosomal Storage Disease Treatment Market
- Malaysia Diabetes Care Drugs Market
- Malaysia Oral Anti-Diabetic Drug Market
- Mexico Diabetes Drugs Market
- Mexico Oral Anti-Diabetic Drug Market
- Middle East and Africa Alpha-Glucosidase Inhibitors Market
- Middle East and Africa Biguanide Market
- Middle East and Africa Diabetes Drugs Market
- Middle East And Africa Dipeptide Peptidase 4 (DPP-4) Inhibitors Market
- Multiple Myeloma Market
- Myelodysplastic Syndrome (MDS) Treatment Market
- New Zealand Diabetes Drugs Market
- New Zealand Oral Anti-Diabetic Drug Market
- Non-Hodgkin Lymphoma Therapeutics Market
- Non-Small Cell Lung Cancer (NSCLC) Market
- North America Biguanide Market
- North America Diabetes Drugs Market
- North America Dipeptide Peptidase 4 (DPP-4) Inhibitors Market
- North America Oral Anti-Diabetic Drug Market
- North America Over the Counter Drugs Market
- Oman Diabetes Drugs Market
- Omeprazole and Antihistamine Market
- Oral Anti-Diabetic Drugs Market
- Oral Cancer Therapy Market
- Over The Counter Drugs Market
- Peptide Therapeutics Market
- Peripheral Neuritis Treatment Market
- Philippines Diabetes Care Drugs Market
- Polypill Products Market
- Proton Pump Inhibitors Market
- Russia Diabetes Drugs Market
- Saudi Arabia Diabetes Drugs Market
- Short Bowel Syndrome Market
- Sleep Disorders Treatment Market
- South Africa Diabetes Drugs Market
- South Korea Diabetes Drugs Market
- Spain Diabetes Care Drugs Market
- Spain Over-the-counter (OTC) Drugs Market
- Subcutaneous Immunoglobulin Market
- Thailand Diabetes Care Drugs Market
- Thyroid Gland Disorders Treatment Market
- Tyrosine Kinase Inhibitors Market
- Ubiquitin Proteasome Market
- Ulcerative Colitis Market
- United Kingdom (UK) Diabetes Drugs Market
- US Diabetes Care Drugs Market
- Vietnam Diabetes Care Drugs Market
- Von Willebrand Disease Treatment Market
